DiviDrip · PLX

PLX — Protalix BioTherapeutics, Inc.

PLX is Protalix BioTherapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $2.67. Market cap: $211M. Capital Quality Rank: 65/100 — Above average.

Stock snapshot

Price$2.67
Market cap$211M
SectorHealthcare
ExchangeASE
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)65 / 100 · Above average
ROIC (TTM)-13.0%
Revenue CAGR (3y)3.5%
Shareholder buyback yield3.20%
Altman Z-score zoneSafe

About PLX

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Listed1996Employees226HQHackensack, NJSectorHealthcareWebsiteprotalix.com

Related non-dividend companies

Other non-dividend stocks investors research alongside PLX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is PLX's current stock price?

PLX (Protalix BioTherapeutics, Inc.) is currently trading at $2.67.

Does PLX pay a dividend?

PLX (Protalix BioTherapeutics, Inc.) does not currently pay a regular dividend.

What is PLX's Capital Quality Rank?

PLX has a Capital Quality Rank of 65/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track PLX in DiviDrip

Add PLX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow